Description: LevoCept is an IUD product. It consists of a flexible shape memory frame and a reservoir containing 52 mg of levonorgestrel.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Intrauterine

Duration Type: Long-acting

  • single

Dose: 52 mg

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: ContraMed, LLC

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase II

Active Development: Yes

Status Details:
  • Phase 2 clinical study to evaluate the effectiveness, safety and tolerability of LevoCept began in the US in November, 2016 with estimated study completion in April, 2021.

Additional Information


Vertical Tabs